JP Morgan Private Capital, JP Morgan’s venture capital and growth equity investment team has held the final close of 270 Life Sciences Private Capital Fund I, above its $500m target.
LSPCF received commitments from institutional allocators, strategic corporate partners, family offices and HNWIs across North America, Europe, the Middle East and Asia, as well as JPMorgan Chase & Co. The fund close was led by CIO Stephen Squinto and Managing Partner Gaurav Gupta.
LSPCF invests in private biotechnology companies spanning cardiometabolic disease, oncology, immunology and genetic medicines.
Source:Private Equity Wire
Can’t stop reading? Read more
Blackstone explores £1bn sale of UK rental platform Leaf Living
Blackstone explores £1bn sale of UK rental platform Leaf Living Blackstone has hired advisers to...
CD&R targets $26bn as mega-fundraising tests LP appetite
CD&R targets $26bn as mega-fundraising tests LP appetite Clayton, Dubilier & Rice is...
Top private equity news of the week
Top private equity news of the week KKR has agreed to acquire Arctos Partners in a transaction...
